- Home
- » Tags
- » Thrombolysis
Top View
- Research Article Association of Platelet Membrane Glycoprotein HPA-2A/B, GP VI T13254C, and GP Ib VNTR Polymorphisms With
- Coagulation Factor XII, XI, and VIII Activity Levels and Secondary Events After First Ischemic Stroke
- Thrombolysis in Acute Ischaemic Stroke
- Tissue Factor Pathway Inhibitor on Circulating Microparticles in Acute
- Thrombophilia: Deficiencies in Protein C, Protein S and Antithrombin
- Tpa for Stroke – Potential Benefit, Risk and Alternatives
- Thrombin Generation and Activity During Thrombolysis and Concomitant Heparin Therapy in Patients with Acute Myocardial Infarction
- Clinical Policy: Protein C Concentrate, Human (Ceprotin)
- Repeated Thrombolytic Therapy After Initial Unsuccessful Thrombolysis in Massive Pulmonary Embolism Bronchial Hyperresponsivenes
- Plasma Contact Activation: a Revised Hypothesis
- Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute Ischemic Stroke in the Emergency Department
- Example of a Protocol for Intra-Arterial Thrombolysis
- ANTICOAGULANT, THROMBOLYTIC, and ANTI-PLATELET DRUGS
- Coagulation and Fibrinolytic Activity of Tenecteplase and Alteplase in Acute Ischemic Stroke
- Guideline for Reversal of Antithrombotics in Intracranial
- Effects of Plasmin on Von Willebrand Factor Multimers. Degradation in Vitro and Stimulation of Release in Vivo
- Tissue Plasminogen Activator
- Low Factor XIII Levels After Intravenous Thrombolysis Predict Short-Term
- Risk Factors Associated with Outcomes of Recombinant Tissue Plasminogen Activator Therapy in Patients with Acute Ischemic Stroke
- Treatment of Dural Sinus Thrombosis by Urokinase Infusion
- Contact Phase of Blood Coagulation and Thrombosis and Hypertension: the Conundrum Has to Be Clarified
- Platelet-Mediated Modulation of Fibrinolysis
- A Study on Coagulation Profile of Patients Thrombolysed with Streptokinase in Acute St-Elevation Myocardial Infarction
- Elevated Factor VIII and Von Willebrand Factor Levels Predict Unfavorable Outcome in Stroke Patients Treated with Intravenous Thrombolysis
- Alteplase (Recombinant Tissue Plasminogen Activator, Rt-PA) for the Treatment of Acute Ischemic Stroke
- Functional Characterization of Antithrombin Mutations by Monitoring of Thrombin Inhibition Kinetics